awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38077440-4BB95FE0-D526-442D-867D-1BDD22E2B391
Q38077440-4BB95FE0-D526-442D-867D-1BDD22E2B391
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38077440-4BB95FE0-D526-442D-867D-1BDD22E2B391
Safety and feasibility of targeted agent combinations in solid tumours.
P2860
Q38077440-4BB95FE0-D526-442D-867D-1BDD22E2B391
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38077440-4BB95FE0-D526-442D-867D-1BDD22E2B391
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d2949263c09de75c60c8617c4b26c65dae1ae31f
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.